FDA Drug Topics: Development and U.S. Regulation of Preventative Vaccines - September 27, 2022

FDA Drug Topics: Development and U.S. Regulation of Preventative Vaccines - September 27, 2022

176th Meeting of the Vaccines and Related Biological Products Advisory CommitteeПодробнее

176th Meeting of the Vaccines and Related Biological Products Advisory Committee

Regulatory and Clinical Trials for TherapeuticsПодробнее

Regulatory and Clinical Trials for Therapeutics

Virtual Public Meeting on Patient-Focused Drug Development for Long COVIDПодробнее

Virtual Public Meeting on Patient-Focused Drug Development for Long COVID

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 1Подробнее

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 2 – Part 1

November 9, 2022 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)Подробнее

November 9, 2022 Meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC)

SBIA Program Overview - REdI 2020Подробнее

SBIA Program Overview - REdI 2020

180th Meeting of Vaccines and Related Biological Products Advisory CommitteeПодробнее

180th Meeting of Vaccines and Related Biological Products Advisory Committee

FDA Webinar on the Infant Formula Transition Plan for Exercise of Enforcement Discretion (Part 1)Подробнее

FDA Webinar on the Infant Formula Transition Plan for Exercise of Enforcement Discretion (Part 1)

Vaccines and Related Biological Products Advisory Committee – 6/10/2021Подробнее

Vaccines and Related Biological Products Advisory Committee – 6/10/2021

FDA Webinar on the Guidance for Industry on Infant Formula Enforcement Discretion PolicyПодробнее

FDA Webinar on the Guidance for Industry on Infant Formula Enforcement Discretion Policy

What a Manufacturer or Vape Shop Should Do After Receiving a Warning Letter.Подробнее

What a Manufacturer or Vape Shop Should Do After Receiving a Warning Letter.

FDA’s Overdose Prevention Framework with Dr. Marta SokolowskaПодробнее

FDA’s Overdose Prevention Framework with Dr. Marta Sokolowska

179th Meeting of Vaccines and Related Biological Products Advisory Committee - Day 1Подробнее

179th Meeting of Vaccines and Related Biological Products Advisory Committee - Day 1

Regulatory Education for Industry (REdI) Annual Conference 2022 - Day 2 - Part 2Подробнее

Regulatory Education for Industry (REdI) Annual Conference 2022 - Day 2 - Part 2

Introduction to Regulatory Science at the FDAПодробнее

Introduction to Regulatory Science at the FDA

Vaccines and Related Biological Products Advisory Committee meetingПодробнее

Vaccines and Related Biological Products Advisory Committee meeting

Writing the “Indications and Usage” Section of Labeling: FDA’s New Draft Guidance – Sep. 27, 2018Подробнее

Writing the “Indications and Usage” Section of Labeling: FDA’s New Draft Guidance – Sep. 27, 2018

FDA Drug Topics Understanding Generic Narrow Therapeutic Index Drugs November 1, 2022Подробнее

FDA Drug Topics Understanding Generic Narrow Therapeutic Index Drugs November 1, 2022